FDA Blocks Moderna's mRNA Flu Vaccine Application Amid Heightened Scrutiny
Published on: Feb. 11, 2026, 6:26 a.m. | Source: Devdiscourse
The FDA has refused to consider Moderna's application for a new flu vaccine using mRNA technology, criticizing the design of its clinical trial. Despite the agency's concerns, Moderna argues there are no safety or efficacy issues. The refusal is part of increased FDA scrutiny under Health Secretary Robert F Kennedy Jr.
